Market Research Logo

Global Dermatology Partnering 2014-2019: Deal trends, players and financials

Global Dermatology Partnering 2014-2019: Deal trends, players and financials

The Global Dermatology Partnering 2014-2019: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in Dermatology partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Dermatology partnering agreement structure
Dermatology partnering contract documents
Top Dermatology deals by value
Most active Dermatology dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive dermatology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dermatology deals.

The report presents financial deal terms values for Dermatology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of dermatology dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in dermatology dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading dermatology deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active dermatology dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to dermatology deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all dermatology partnering deals by specific dermatology target announced since 2014. The chapter is organized by specific dermatology therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

Report scope

Global Dermatology Partnering 2014-2019 is intended to provide the reader with an in-depth understanding and access to dermatology trends and structure of deals entered into by leading companies worldwide.

Global Dermatology Partnering 2014-2019 includes:

Trends in dermatology dealmaking in the biopharma industry since 2014
Analysis of dermatology deal structure
Access to headline, upfront, milestone and royalty data
Access to over 700 dermatology deal records
The leading dermatology deals by value since 2014

The report includes deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles, plus other dermatology indications.

In Global Dermatology Partnering 2014-2019, the available deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy target

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Dermatology Partnering 2014-2019 report provides comprehensive access to available deals and contract documents for over 650 dermatology deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are the sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


  • Executive Summary
  • Introduction
  • Trends in Dermatology dealmaking
    • Introduction
    • Dermatology partnering over the years
    • Dermatology partnering by deal type
    • Dermatology partnering by industry sector
    • Dermatology partnering by stage of development
    • Dermatology partnering by technology type
    • Dermatology partnering by therapeutic indication
  • Financial deal terms for Dermatology partnering
    • Introduction
    • Disclosed financials terms for Dermatology partnering
    • Dermatology partnering headline values
      • Table Dermatology deals with a headline value
    • Dermatology deal upfront payments
      • Table Dermatology deals with upfront payment values
    • Dermatology deal milestone payments
      • Table Dermatology deals with milestone payment
    • Dermatology royalty rates
      • Table Dermatology deals with royalty rates
  • Leading Dermatology deals and dealmakers
    • Introduction
    • Most active in Dermatology partnering
    • List of most active dealmakers in Dermatology
      • LEO Pharma
      • Avita Medical
      • National Psoriasis Foundation
      • Almirall
      • Valeant Pharmaceuticals
      • Cipher Pharmaceuticals
      • GlaxoSmithKline
      • MediWound
      • Premier Inc
      • Allergan
      • Biomedical Advanced Research and Development Authority
      • Covalon Technologies
      • Galderma
      • Nuo Therapeutics
      • Olaregen Therapeutix
      • Sanuwave Health
      • APR Applied Pharma Research
      • Brickell Biotech
      • Dermira
      • Johnson & Johnson Innovation
      • Novartis
      • Nuvo Pharmaceuticals
      • Pierre Fabre
      • Abbvie
      • Acelity
    • Top Dermatology deals by value
      • Table Top Dermatology deals by value since 2014
  • Dermatology contract document directory
    • Introduction
    • Dermatology partnering deals where contract document available
  • Dermatology dealmaking by therapeutic target
    • Introduction
    • Deals by Dermatology therapeutic target
      • Dermatology
      • Acne
      • Actinic keratosis
      • Angioedema
      • Burns
      • Cellulitis
      • Cosmetics
      • Dermatitis
      • Diabetic foot ulcer
      • Eczema
      • Hair disorders
      • Alopecia
      • Impetigo
      • Itching
      • Nail disorders
      • Psoriasis
      • Rosacea
      • Rash
      • Scar
      • Venous ulcer
      • Vitiligo
      • Wound healing
      • Wrinkles
  • Appendices
    • Directory of Dermatology deals by company A-Z 2014 to 2019
      • 3D Systems
      • 3M Critical & Chronic Care Solutions
      • Abbvie
      • Accelis Pharma
      • AccuTec Blades
      • Acelity
      • Acell
      • Aclaris Therapeutics
      • Actavis (name changed to Allergan)
      • Actelion
      • ADB International Group
      • Adhesys Medical
      • Advanced BioScience Laboratories
      • Advanced Medical Solutions
      • Advanced Plasma Products
      • Aesthetic Management Partners
      • Afinity Life Sciences
      • Aghraas-Cigalah
      • Air Force Research Laboratory
      • Akaal Pharma
      • Alat Medika Indonesia
      • Alibaba Health
      • Allergan
      • Alliance Pharma
      • Alliqua Biomedical
      • AlloSource
      • Almirall
      • Alpha Pharma
      • Amarantus BioSciences
      • American Academy of Professional Coders
      • American Red Cross
      • American Skin Association
      • AMI
      • AMNIOX
      • Amor (Suzhou) Medical Sci-Tech
      • AMSilk
      • Amyris
      • Andrew Technologies
      • Angelini Pharma
      • AnGes MG
      • Angionetics
      • Anika Therapeutics
      • ANI Pharmaceuticals
      • Anteis
      • Anterios
      • Antibe Therapeutics
      • AOTI
      • APL
      • Applied Biology
      • Apria Healthcare Group
      • APR Applied Pharma Research
      • Aqua Pharmaceuticals
      • Aralez Pharmaceuticals
      • Aratana Therapeutics
      • Arcutis
      • ArGEN-X
      • Arrevus
      • Arrien Pharmaceuticals
      • Arsenal Medical
      • Arthrex
      • Art of Technology
      • Aslan Pharma
      • Astellas Pharma
      • Astion Pharma
      • AstraZeneca
      • ATG Allied Technologies
      • Athenex
      • Atopix
      • Aucta Pharmaceuticals
      • Austen BioInnovation Institute in Akron (ABIA)
      • Auven Therapeutics
      • Avalon Pharmaceuticals
      • Avaria Health & Beauty
      • Avita Medical
      • Axcelon Dermacare
      • Axonlab
      • Azitra
      • Back-A-Line
      • Basilea Pharmaceutica
      • Bassett Salon Solutions
      • Bayer
      • Baylor Research Institute
      • Bellus Health
      • Berkshire Sterile Manufacturing
      • Berlin Chemie
      • Best Choice
      • BexPharm
      • BioCad Holding
      • BioDerm
      • BioDlogics
      • Biogen
      • BiolineRX
      • Biomedical Advanced Research and Development Authority
      • BIOMEDX Group
      • BioMed X Innovation Center
      • Biometrix
      • Bionpharma
      • Biophage Pharma
      • BioPharm Group International
      • Bioskin
      • BirchBioMed
      • Bloomage BioTechnology
      • BMG Pharmaceuticals
      • Boehringer Ingelheim
      • Boston Pharmaceuticals
      • Boston Topicals
      • BoyaLife
      • Bpifrance
      • Brickell Biotech
      • Brigham and Women's Hospital
      • Bright Future Pharmaceutical Lab
      • BSN Medical
      • B Braun
      • Cadila Pharmaceuticals
      • Caliber Imaging & Diagnostics
      • Can-Fite BioPharma
      • CANbridge Life Sciences
      • CannaSkin
      • CanniMed Therapeutics
      • Cantel Medical (UK)
      • Cardiome Pharma
      • Carestream Health
      • Case Western Reserve University
      • Castle Creek Pharmaceuticals
      • CDx Diagnostics
      • Celgene
      • CellMark Medical
      • Certara
      • CHAMPS Group Purchasing
      • Chemipal
      • Children's Hospital Boston
      • China-Israel Biological Technology
      • Chongqing Jingdong Pharmaceutical
      • Chong Kun Dang
      • Chromogenex Technologies
      • Chugai Pharmaceutical
      • Cimtech
      • Cincinnati Children's Hospital Medical Center
      • Cipher Pharmaceuticals
      • Circadia
      • Clarify Medical
      • Clinipace Worldwide
      • CMS Medical
      • Collagen Solutions LLC
      • Collagen Solutions Plc
      • Collplant
      • Columbia University Medical Center
      • ConBio (Shanghai)
      • Contem 1G
      • ConvaTec
      • Cook Biotech
      • Cooper-Vemedia
      • Cosmotec
      • Covaleo
      • Covalon Technologies
      • CROMA Pharma
      • Cronos Group
      • Crown Bioscience
      • Crown Laboratories
      • Cumberland Pharmaceuticals
      • Curetis
      • Cutanea Life Sciences
      • Cutanogen
      • Cytori Therapeutics
      • CytoSorbents
      • Dalhousie University
      • Daniel Alain Life Science
      • DASH Analytics
      • Dasman Diabetes Institute
      • Daxor
      • Denali Therapeutics
      • Department of Defence
      • Department of Defense
      • Department of Veterans Affairs
      • DermaConcepts
      • Dermala
      • Dermata Therapeutics
      • Dermavant Sciences
      • Derma Sciences
      • Dermelix Biotherapeutics
      • Dermira
      • Dermpath Diagnostics
      • DermSpectra
      • DermTech
      • Dipexium Pharmaceuticals
      • Diplomat
      • Dr. Falk Pharma
      • Dr. Reddy's Laboratories
      • Dr. U Devices
      • DS Healthcare
      • Ducere Pharma
      • Dukal
      • Dynasil
      • E-QURE
      • Eccrine Systems
      • Eclipse Aesthetics
      • Eirion Therapeutics
      • Eisai
      • EKare
      • Elanix Biotechnologies
      • Elektrofi
      • Ember Therapeutics
      • Emory University
      • EMS
      • Enaltus
      • Encore Dermatology
      • Envy Medical
      • Epicore Biosystems
      • EPI Health
      • Espada Dermatology
      • Eurofins Scientific
      • Evolva
      • Ewopharma
      • Exicure
      • Fagron
      • Ferrer International
      • Fidelta
      • Follicum AB
      • Food and Drug Administration (FDA)
      • FormaTK Systems
      • Fougera Pharmaceuticals
      • Freedom Leaf
      • Fujifilm Kyowa Kirin Biologics
      • G-treeBNT
      • Galapagos
      • Galderma
      • Gebro Pharma
      • Gecko Biomedical
      • Geisel School of Medicine at Dartmouth
      • Genentech
      • General Biologicals
      • Gene Biotherapeutics
      • Genfa Medica
      • GHD GesundHeits
      • GlaxoSmithKline
      • GlobalMed
      • GPC Systems
      • Grunenthal
      • Grupo Ferrer
      • GtreeBNT
      • H2-Pharma
      • Hairmore Group
      • Hapten Sciences
      • Harvard Medical School
      • Helsinn Healthcare
      • Hemostasis
      • Heptares Therapeutics
      • Heumann Pharma Generics
      • Hill Dermaceuticals
      • Histocell
      • Histogen
      • Hoth Therapeutics
      • Huapont Pharma
      • Hugel
      • Iagnosis
      • Icahn School of Medicine at Mount Sinai
      • Ice + Jam
      • Ideal Medical Solutions
      • IFyber
      • ImaBiotech
      • Imbed Bio
      • IME Medical Electrospinning
      • IMIDomics
      • Immune Pharmaceuticals
      • Immunomic
      • Induce Biologics
      • Innate Biologics
      • Innovate UK
      • Innovative Cellular Therapeutics
      • Innovus Pharmaceuticals
      • Inova Diagnostics
      • Institute for In Vitro Sciences
      • Intalere
      • Integra LifeSciences
      • Intermountain Healthcare
      • Interpolymer/Zschimmer & Schwarz
      • Intralytix
      • ISIS Innovation
      • Isoprene Pharmaceuticals
      • Israeli National Authority for Technological Innovation
      • ITEM Medical Technologies
      • Jackson Laboratory
      • Janssen Biotech
      • Janssen Pharmaceuticals
      • Janssen Pharmaceutica NV
      • Janssen Research & Development
      • Japan Tobacco
      • JCR Pharmaceuticals
      • Jiangsu Hengrui Medicine
      • Johnson & Johnson Consumer Companies
      • Johnson & Johnson Innovation
      • Juntendo University
      • JW Pharmaceutical
      • Kaken Pharmaceutical
      • Karyopharm Therapeutics
      • Kavo Kerr Group
      • Kent Imaging
      • Kerecis
      • Kinetic Concepts
      • King's College Hospital
      • Kleresca
      • KLOX Technologies
      • Knight Therapeutics
      • Kramer Laboratories
      • Kuwait Life Sciences
      • KYERON Medical Innovations
      • Kyocera
      • Kythera Biopharmaceuticals
      • L'Oreal
      • Laboratorios Andromaco
      • Lannett
      • Laser Lab Corp
      • Lautus Pharmaceuticals
      • Lead Pharma
      • Legacy Biotechnologies
      • Lenus Therapeutics
      • Leon-nanodrugs
      • LEO Pharma
      • Libbs Farmaceutica
      • LifeCell
      • LifeMax Laboratories
      • Lifenet
      • Ligand Pharmaceuticals
      • LiLa Enterprise
      • Lipidor
      • Living Proof
      • Lonza
      • Loreal
      • Lupin
      • Luqa Pharmaceuticals
      • Maco Pharma
      • MacroCure
      • Mamba Instruments
      • Massachusetts General Hospital
      • Matawan Pharmaceuticals
      • Maxhealth Medicine
      • Mayne Pharma
      • Mayo Clinic
      • MDS Pharma Services
      • Med-Aesthetic Solutions
      • Medela
      • Medical College of Wisconsin
      • MediGene
      • Medimetriks
      • Mediq
      • MediWound
      • Medline Industries
      • MedPharm
      • Medshift
      • Medybloom
      • Medytox
      • MELA Sciences
      • MEME
      • Menlo Therapeutics
      • Merck and Co
      • Merz
      • Mesoblast
      • Metrion Biosciences
      • Michelson Diagnostic
      • Michepro
      • Milestone Advanced Cosmetic Systems
      • Milestone China
      • Milestone Scientific
      • Millennium Medical Devices
      • MiNDERA
      • Mintcare
      • Mitsubishi Tanabe Pharma
      • Moberg Pharma
      • Modoc Research Services
      • Molnlycke Health Care
      • Momenta Pharmaceuticals
      • Monash University
      • MorphoSys
      • MSM-Medimpex
      • MTF Biologics
      • Mundimed
      • Mundipharma
      • Musculoskeletal Transplant Foundation
      • MWMedical
      • Mylan Pharmaceuticals
      • Nabriva Therapeutics
      • Nanning Xinzizhu Trading
      • NanoVibronix
      • National Institutes of Health
      • National Institute for Food and Drug Control
      • National Institute of Allergy and Infectious Diseases
      • National Institute of Arthritis and Musculoskeletal Diseases
      • National Institute of General Medical Sciences
      • National Psoriasis Foundation
      • Neovacs
      • Nestle
      • Net Health Systems
      • Neumedicines
      • NewSurg
      • New York University
      • New York University School of Medicine
      • Nordic Pharma Group
      • Northwestern University
      • NovaBay Pharmaceuticals
      • Novadaq Technologies
      • Novan Therapeutics
      • Novartis
      • Novation
      • NovImmune
      • Nuevolution
      • NuGene International
      • NuMedii
      • Nuo Therapeutics
      • Nutriband
      • Nuvo Pharmaceuticals
      • Oakrum Pharma
      • Office of Naval Research
      • Olaregen Therapeutix
      • Omega Pharma
      • Oncodesign
      • OptiBiotix
      • Orca Pharmaceuticals
      • Organogenesis
      • Organovo
      • Organ Technologies
      • Orphan Europe
      • Osiris Therapeutics
      • Otsuka
      • OWC Pharmaceutical Research
      • Pacgen Biopharmaceuticals
      • Palvella Therapeutics
      • Parcell Laboratories
      • Parnell Pharmaceutical Holdings
      • Particle Sciences
      • Patient-Centered Outcomes Research Institute (PCORI),
      • PCG Clinical Services
      • PellePharm
      • Perrigo
      • Perry Baromedical
      • Peterson's Lab
      • Pfizer
      • PharmaResearch Products
      • Pharming Group
      • Pharmstandard
      • Phase Holographic Imaging
      • Phosphagenics
      • PhotoMedex
      • Piedmont Pharmaceuticals
      • Pierre Fabre
      • Pierre Fabre Dermatologie
      • Piqur Therapeutics
      • Platine Pharma Services
      • Portola Pharmaceuticals
      • Premier Inc
      • Prestium Pharma
      • Prime Therapeutics
      • Principle Business Enterprises
      • Promius Pharma
      • Promore Pharma
      • Proscia
      • Protagen
      • Pura Naturals
      • Purdue Pharma
      • Pure Med Farma
      • Pyramid Biosciences
      • Quest PharmaTech
      • RAHN
      • Randob Labs
      • Rational Surgical Solutions
      • Recipharm
      • Regenerative Biologics
      • Regenerx
      • Regenicin
      • Replicel Life Sciences
      • Restorix Health
      • Rigel Pharmaceuticals
      • RIKEN Yokohama Institute Omics Science Center
      • Rochal Industries
      • Roche
      • Rockefeller University
      • Rodan and Fields
      • Rogne Bioscience
      • Rohto Pharmaceutical
      • Roivant Sciences
      • ROi (Resource Optimization & Innovation)
      • RRD International
      • RXi Pharmaceuticals
      • Samsung Bioepis
      • Samsung Biologics
      • Samumed
      • Sanofi
      • Santalis Pharmaceuticals
      • Sanuwave Health
      • Saraya
      • SastoMed
      • Sato Pharmaceutical
      • Scapa Healthcare
      • SciBase
      • Science 37
      • Sciton
      • Second Genome
      • Sensus Healthcare
      • SenzaGen
      • SerenaGroup
      • Shanghai Corday Biotech
      • Shire Pharmaceuticals
      • Signum Biosciences
      • Signum Dermalogix
      • Sinclair IS Pharma
      • Sincopharm
      • Sinopharm
      • Sinovant Sciences
      • Sirona Biochem
      • Skin
      • SkinBiotix
      • Skincential Sciences
      • Skinvisible
      • Smart Cell Tec
      • SMG Pharmaceuticals
      • Smith & Nephew
      • Sol-Gel
      • Solomomo
      • Somanetics
      • Sonoma Pharmaceuticals
      • Southmedic
      • Southwest Transplant Alliance
      • Spear Pharmaceuticals
      • Spiracur
      • Squalan Natural Health
      • Stiefel Laboratories
      • Stratatech
      • Stratpharma
      • Suneva Medical
      • Sun Pharmaceutical
      • Swiss Institute of Allergy and Asthma Research
      • SYnergy Medsales
      • Syneron Medical
      • Systagenix Wound Management
      • Takeda Pharmaceutical
      • Taureon
      • Tauriga Sciences
      • Taxus Cardium Pharmaceuticals
      • Teb Sanaat Lotus
      • Tec-Pharm
      • Tec-Pharma
      • TechCare
      • Technion Research and Development Foundation
      • Technology Strategy Board (UK)
      • Terumo Cardiovascular Systems
      • Teva-tuteur
      • TheraVida
      • The HydraFacial Company
      • Thomas Jefferson University
      • Tissue Analytics
      • Tissue Regenix
      • Tissue Regenix Group
      • Tiziana Life Sciences
      • Torii Pharmaceutical
      • TRX Wound Care
      • TWi Pharmaceuticals
      • UBiome
      • UCB
      • Ueno
      • Uluru
      • Uni-Bio Science
      • University of Alabama at Birmingham
      • University of British Columbia
      • University of California Los Angeles
      • University of California San Francisco
      • University of Cincinnati
      • University of Colorado Denver
      • University Of Huddersfield
      • University of Manchester
      • University of Maryland Baltimore
      • University of Massachusetts
      • University of Michigan
      • University of Oxford
      • University of Pennsylvania
      • University of Pittsburgh
      • University of Pittsburgh Medical Center
      • University of Washington
      • University of Wisconsin
      • Upside Biotechnologies
      • US Army
      • US Army Medical Research and Material Command
      • US Department of Veteran Affairs
      • US Navy
      • Valeant Canada Limited
      • Valeant Pharmaceuticals
      • Valeo Pharma
      • Vancive Medical Technologies
      • Vasomune Therapeutics
      • Vericel
      • Virginia Commonwealth University
      • ViroXis
      • Visualant
      • VisualDx
      • VitaThreads
      • Vitruvias Therapeutics
      • Vizient
      • Vomaris Innovations
      • Wearifi
      • Weill Cornell Medical College
      • Wellness Center USA
      • WellSpring Pharmaceutical
      • Wirthlin-Denton
      • Wistar Institute
      • WOUNDCHEK Laboratories
      • Wound Care Advantage
      • X-chem
      • Xcede Technologies
      • XCellR8
      • Xycrobe Therapeutics
      • Yale School of Medicine
      • Yissum Research Development
      • YL Biologics
      • YOFOTO (China) Health Industry
      • Yoshindo
      • YuYang DNU
      • Z-Medica
      • Z-Medical
      • ZappRx
      • Zenoaq
      • ZetrOZ
      • Ziarco Pharma
      • Zikad International Aesthetics Supplier
      • Zuellig Pharma China
      • Zymeworks
    • Directory of Dermatology deals by deal type 2014 to 2019
      • Asset purchase
      • Assignment
      • Bigpharma outlicensing
      • Co-development
      • Collaborative R&D
      • Co-market
      • Co-promotion
      • CRADA
      • Cross-licensing
      • Development
      • Distribution
      • Equity purchase
      • Evaluation
      • Grant
      • Joint venture
      • Licensing
      • Litigation
      • Manufacturing
      • Marketing
      • Option
      • Promotion
      • Research
      • Settlement
      • Spin out
      • Supply
      • Termination
    • Directory of Dermatology deals by stage of development 2014 to 2019
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
      • Formulation
    • Directory of Dermatology deals by technology type 2014 to 2019
      • Analysis
      • Animal models
      • Antibiotics
      • Clindamycin
      • Quinolones
      • Antibodies
      • Antibody-drug conjugate
      • Bispecific antibodies
      • Monoclonal antibodies
      • Humanized mAb
      • Human mAb
      • AI/Artificial intelligence
      • Assays
      • Biological compounds
      • Biomarkers
      • Biomaterials
      • Bioprocessing
      • Biosimilars/Bio-betters
      • Blood products
      • Cell culture
      • Clinical testing
      • Devices
      • Surgical devices
      • Wearable devices
      • Diagnostics
      • Companion
      • Imaging
      • In vitro diagnostics
      • Molecular diagnostics
      • Discovery tools
      • Compound screening library
      • Drug delivery
      • Oral delivery
      • Injectable
      • Topical
      • Transdermal
      • Ocular
      • Enabling technology
      • Equipment
      • Facilities
      • Genomics
      • Implant
      • Microbiome
      • Nanotechnology
      • Natural product
      • Packaging
      • Peptides
      • Personalised medicine
      • Photonics
      • Proteomics
      • Radio/Chemo-therapy
      • Recombinant DNA
      • Regenerative medicine
      • Anti-aging
      • Cell therapy
      • Organ regeneration
      • Stem cells
      • Tissue regeneration
      • Research services
      • Research supplies
      • RNA therapeutics
      • Screening
      • Small molecules
      • Software tools
      • Toxicity
      • Vaccines
      • DNA vaccine
      • Wearable technology
    • Further reading on dealmaking
    • Deal type definitions
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from CurrentPartnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report